Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression.
about
Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factorAngiotensin induces the urinary peristaltic machinery during the perinatal periodPositive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo.ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development.Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18 S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor.The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells.A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements.Molecular control of vascular smooth muscle cell differentiation.Control of the renal medullary circulation by vasopressin V1 and V2 receptors in the rat.Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Characterisation of the promoter which regulates expression of a phosphoglucomutase-related protein, a component of the dystrophin/utrophin cytoskeleton predominantly expressed in smooth muscle.Contractile force is enhanced in Aortas from pendrin null mice due to stimulation of angiotensin II-dependent signaling.Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissuesAngiotensin II, from vasoconstrictor to growth factor: a paradigm shift.Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility.A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative ProteomicsSuppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2.Effect of the Na+/H+ antiport inhibitor Hoe 694 on the angiotensin II-induced vascular smooth muscle cell growth.Regulation of SM22 alpha expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells.Galpha16 mimics vasoconstrictor action to induce smooth muscle alpha-actin in vascular smooth muscle cells through a Jun-NH2-terminal kinase-dependent pathway.Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels.Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression.Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis.[The renin-angiotensin system in cardiovascular diseases].Gbeta gamma mediate differentiation of vascular smooth muscle cells.
P2860
Q28572551-A29FE297-E420-4F85-A42A-FCD35F11FA2EQ28592988-D5067FEC-EF8D-4B95-8A38-B96902AE7FCEQ30305991-95114639-B3BE-439D-B865-68FDB0272D12Q30434317-94D4694E-6DA6-400B-AA0F-D6C4B236829CQ30464081-518E44AB-89BD-4EE0-962E-BADE9486F238Q30464808-49442D84-0015-4FE2-84FE-CE050E4FE981Q30470269-CF97AF2F-CF45-4E54-B46C-50BBE13B7C44Q30473015-B3C9E039-7458-49E7-A163-FEB94F267CECQ30867263-1A095E34-4AF0-43B0-9379-4CA306CA377BQ34146262-AA008EA7-3DAF-4ED5-90D5-86B32C549D14Q34443541-816A28C9-416B-428D-A136-E085A989E9EDQ35229772-51A898ED-06CD-457E-9D06-6855E20F9E27Q35764359-973F9300-B303-4A19-B314-26B36FF5C95BQ35871055-E344C17F-6638-4D7B-8DAA-85DDA9379380Q37701122-6995440C-71CC-490C-BE2E-B37259FEAD2CQ40036253-41A2DC62-B141-464C-8968-759C786B92A3Q41098279-95CDE757-39A5-4082-8182-FC5B0C787D43Q41975446-724B30F9-A53C-4688-BA5D-134E8E1A38C7Q42112210-2CB66070-8BC1-410F-9973-C4580AA6624DQ42443795-7BCA3A3F-1BCC-47A5-8E92-DC85C5539337Q42445221-7E57EAED-6D02-470D-ABCB-51DC5FA6F850Q42613297-BD2DC560-FCA1-4C04-A987-1E09142C3E6AQ43737904-210D9E47-1F9B-41CC-AF1E-63A129758A2CQ44894343-9AA26000-AD23-4E08-8557-C2E1488A3126Q48750342-77FA96BA-00E3-4859-B0A5-B65FDDA78C4FQ52965356-041327BA-65CD-4B34-9B93-E3A529E722E5
P2860
Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Mechanisms of angiotensin II- ...... th muscle isoactin expression.
@ast
Mechanisms of angiotensin II- ...... th muscle isoactin expression.
@en
type
label
Mechanisms of angiotensin II- ...... th muscle isoactin expression.
@ast
Mechanisms of angiotensin II- ...... th muscle isoactin expression.
@en
prefLabel
Mechanisms of angiotensin II- ...... th muscle isoactin expression.
@ast
Mechanisms of angiotensin II- ...... th muscle isoactin expression.
@en
P2093
P356
P1433
P1476
Mechanisms of angiotensin II- ...... th muscle isoactin expression.
@en
P2093
P304
P356
10.1161/01.RES.68.1.288
P577
1991-01-01T00:00:00Z